NIH Funding: Independent Labs Have Best Success Rate

Compared to university- and hospital-affiliated labs, independent research labs apply for few NIH grants. And the research money they eventually receive amounts to less than 10% of what NIH gives out. However, if you were to look at their success rate in getting grants, the independents outdo their counterparts at universities and hospitals. That conclusion can be drawn from a comparison NIH recently made of various classes of applicants' success rates (the percentage of research applications

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

That conclusion can be drawn from a comparison NIH recently made of various classes of applicants' success rates (the percentage of research applications that are actually approved for funding).

Between 1978 and 1987, the independent labs NIH studied - all members of the Association of Independent Research Institutes (AIRI) - consistently showed a higher-than-average success rate of research grants. For some years, the advantage was slight, such as 1.3% in 1981. But in 1987, the gap widened dramatically: 44.7% of AIRI applicants won grants. In contrast, the overall average was 35.4%.

TI: SCIENCE GRANTS Below is a list of notable grants recently awarded in the sciences - large federal grants as well as awards of all sizes from private foundations. The individual cited with each entry is the project's principal investigator. The National Institutes of Health made the following grants for improving infrastructure for AIDS research: $1 million to Harvard ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies